Podcast Episodes
Back to SearchFrom The Bench To The Boardroom with ImmunityBio's Enrique Diloné
We love to hear from our listeners. Send us a message.
While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash t…
2 years, 1 month ago
First AI Antibody In Humans with Aulos' Aron Knickerbocker
We love to hear from our listeners. Send us a message.
Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its…
2 years, 1 month ago
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs
We love to hear from our listeners. Send us a message.
Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's thr…
2 years, 1 month ago
Topical Ocular Biologics with Claris Bio's Clarke Atwell
We love to hear from our listeners. Send us a message.
Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil …
2 years, 1 month ago
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
We love to hear from our listeners. Send us a message.
When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 20…
2 years, 2 months ago
True DEI Value in Biopharma with Arcellx's Rami Elghandour
We love to hear from our listeners. Send us a message.
The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. …
2 years, 2 months ago
Mission-Driven Dementia Funding with DDF's Jonathan Behr
We love to hear from our listeners. Send us a message.
If there's anyone qualified to analyze an early-stage therapeutic technology and place bets wi…
2 years, 2 months ago
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
We love to hear from our listeners. Send us a message.
Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics s…
2 years, 2 months ago
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
We love to hear from our listeners. Send us a message.
Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwr…
2 years, 3 months ago
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
We love to hear from our listeners. Send us a message.
This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you …
2 years, 3 months ago